Free Trial

Zealand Pharma A/S (ZLDPF) Earnings Date, Estimates & Call Transcripts

Zealand Pharma A/S logo
$45.30 0.00 (0.00%)
As of 05/4/2026 02:40 PM Eastern

Zealand Pharma A/S Earnings Summary

Zealand Pharma A/S posted Q4 2025 earnings on February 19, 2026, reporting an EPS of -$0.81, which beat analysts' consensus estimates of -$1.34 by $0.53. Quarterly revenue was reported to be $10.79 million, below analyst estimates of $19.69 million. With a trailing EPS of $13.68 and a P/E Ratio of 3.31, Zealand Pharma A/S's earnings are expected to decrease next year, from $2.51 to ($1.46) per share.

Q4 2025 Earnings Resources

ZLDPF Upcoming Earnings

Zealand Pharma A/S's next earnings date is estimated for Thursday, May 7, 2026, based on past reporting schedules.

Upcoming Q1
Earnings Date
May. 7Before Market OpensEstimated
Consensus EPS
(Feb. 19)
-$1.34
Actual EPS
(Feb. 19)
-$0.81 Beat By $0.53
Actual Revenue
(Feb. 19)
$10.79M
Get Zealand Pharma A/S Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Zealand Pharma A/S and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ZLDPF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ZLDPF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Zealand Pharma A/S Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$1.55-$1.55-$1.55
Q2 20261-$0.55-$0.55-$0.55
Q3 20261-$1.65-$1.65-$1.65
Q4 20261-$1.69-$1.69-$1.69

Zealand Pharma A/S Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/7/2026
(Estimated)
--------
2/19/2026Q4 2025-$1.34-$0.81+$0.53-$0.81$19.69M$10.79M
11/13/2025Q3 2025-$1.11-$0.90+$0.21-$0.90$4.54M$7.76M
8/14/2025Q2 2025$16.72$16.06 -$0.66$16.06$9.18B$1.43B
5/8/2025Q1 2025-$0.77-$0.67+$0.10-$0.67$248.61M$1.14M
2/20/2025Q4 2024-$0.78-$0.59+$0.19-$0.59$28.11M$1.30M
8/15/2024Q2 2024-$0.61-$0.67 -$0.06-$0.67$0.50M$4.93M
5/16/2024Q1 2024--$0.54--$0.54-$2.20M

Data powered by Fiscal.ai.

Zealand Pharma A/S Earnings - Frequently Asked Questions

Zealand Pharma A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 7th, 2026 based off last year's report dates. Learn more on ZLDPF's earnings history.

In the previous quarter, Zealand Pharma A/S (OTCMKTS:ZLDPF) reported ($0.81) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.34) by $0.53. Learn more on analysts' earnings estimate vs. ZLDPF's actual earnings.

Zealand Pharma A/S (OTCMKTS:ZLDPF) has a recorded annual revenue of $1.40 billion.

Zealand Pharma A/S (OTCMKTS:ZLDPF) has a recorded net income of $977.29 million. ZLDPF has generated $13.68 earnings per share over the last four quarters.

Zealand Pharma A/S (OTCMKTS:ZLDPF) has a trailing price-to-earnings ratio of 3.31 and a forward price-to-earnings ratio of 18.05.

Zealand Pharma A/S's earnings are expected to decrease from $2.51 per share to ($1.46) per share in the next year.


This page (OTCMKTS:ZLDPF) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners